258497-48-2

Basic information

• Product Name: 6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER
• Synonyms: 6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER;METHYL 6-T-BUTOXYCARBONYLAMINO-PYRIDINE-2-CARBOXYLATE;methyl 6-(tert-butoxycarbonylamino)picolinate;2-Pyridinecarboxylic acid, 6-[[(1,1-diMethylethoxy)carbonyl]aMino]-, Methyl ester;methyl 6-tert-butoxycarbonylamino-2-pyridinecarboxylate;methyl 6-({[(tert-butoxy)carbonyl]amino}methyl)pyridine-2-carboxylate
• CAS NO: 258497-48-2
• Molecular Formula: C12H16N2O4
• Molecular Weight: 252.27
• Mol File: 258497-48-2.mol

Chemical Properties

• Boiling Point: 419.3°Cat760mmHg
• Flash Point: 207.4°C
• Appearance: /
• Density: 1.149g/cm³
• Vapor Pressure: 3.07E-07mmHg at 25°C
• Refractive Index: 1.511
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER(258497-48-2)
• EPA Substance Registry System: 6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER(258497-48-2)

Safety Data

• Hazardous Substances Data: 258497-48-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER is used as a building block in the synthesis of various pharmaceuticals and agrochemicals for its potential to inhibit specific enzymes or receptors, making it a valuable tool for drug discovery and design.
Used in Drug Discovery:
In the field of drug discovery, 6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER is used as a chemical intermediate for the development of new therapeutic agents, leveraging its interactions with biological targets to create novel medications.
Used in Agrochemicals:
6-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-2PYRIDINECARBOXYLIC ACID METHYL ESTER is also utilized in the agrochemical industry, serving as a key component in the creation of pesticides or other agricultural chemicals, where its enzyme or receptor inhibition properties can be applied to control pests or diseases.

InChI:InChI=1/C13H18N2O4/c1-13(2,3)19-12(17)14-8-9-6-5-7-10(15-9)11(16)18-4/h5-7H,8H2,1-4H3,(H,14,17)

Upstream product

• 23628-31-1 6-aminopicolinic acid 
• 36052-26-3 methyl 6-aminopyridine-2-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 258497-21-1 6-[(tert-butoxycarbonyl)amino]-2-pyridinecarboxylic acid 
• 67-56-1 methanol 
• 499-83-2 Pyridine-2,6-dicarboxylic acid 
• 7170-36-7 6-(methoxycarbonyl)pyridine-2-carboxylic acid 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 105243-77-4 (6-(methylamino)pyrid-2-yl)methanol 
• 400781-16-0 tert-butyl (6-(bromomethyl)pyridin-2-yl)carbamate 
• 203321-83-9 tert-butyl 6-(hydroxymethyl)-2-pyridinylcarbamate 
• 259533-24-9 3-[4-(2-tert-butoxycarbonylamino-ethylsulfanylmethyl)-[1,2,3]thiadiazol-5-ylsulfanyl]-7-[2-(6-tert-butoxycarbonylamino-pyridin-2-yl)-2-trityloxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 
• 258497-27-7 (6-tert-butoxycarbonylamino-pyridin-2-yl)-trityloxyimino-acetic acid methyl ester 
• 258497-18-6 (Z)-2-(2-tert-butoxycarbonylaminopyrid-6-yl)-2-(triphenylmethoxyimino)acetic acid 

Relevant articles and documents

POLY HETEROCYCLIC CONJUGATES AND THEIR PHARMACEUTICAL USES

Compounds of Formula (I) shown below and a pharmaceutical composition containing one of the compounds: Each of the variables is defined herein. Also disclosed is a method of treating a condition associated with uncontrolled cell growth with a compound of Formula (I).

Phenyl oxime derivative and preparation method and application thereof

The invention relates to a phenyl oxime derivative as well as a preparation method and application thereof. Specifically, the present invention relates to a phenyl oxime derivative represented by formula (I) or a stereoisomer of the phenyl oxime derivativ

ADENOSINE RECEPTOR BINDING COMPOUNDS

The present invention relates to pharmaceutical compounds and compositions of Formula (I) and methods of treatment using the compounds and compositions, especially for the treatment and/or prevention of a proliferation disorder, such as cancer. Compounds of Formula (I) as further described herein are shown modulators of the adenosine A2A receptor and exhibit antiproliferative activity. Accordingly, these compounds are useful to treat proliferative disorders such as cancer, and other adenosine receptor-related conditions including an inflammatory disease, renal disease, diabetes, vascular disease, lung disease, or an autoimmune disease.

2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

The invention provides certain 2-pyridyl carboxamide-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A and B are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.

3,6-DISUBSTITUTED AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS

The present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the prepration of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.

7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof

The present invention relates to a cephem prodrug having formula III or formula IV: or a pharmaceutically acceptable salt thereof, wherein R′1is selected from the group consisting of hydrogen and —C(O)CH(NH2)CH3and R′2is selected from the group consisting of hydrogen and an acyl group that is cleaved by an enzyme found in mammals, with the proviso that, when either R′1or R′2is hydrogen, the other is not. A, B, L, G, E, and J are each independently nitrogen or carbon such that the respective rings are selected from the group consisting of provided that the group —CH2—S—CH2CH2NHR′2is attached only to a carbon atom of said heterocyclic group, and Q is selected from the group consisting of nitrogen and —CX, wherein X is selected from the group consisting of hydrogen and chlorine.

New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position

Incorporation of a basic aminopyridine into the C-7 position of 3-(amine-substituted arylthio)-3-norcephalosporins, as in 3, afforded high potency against MRSA and acceptable solubility for intravenous administration.

Cephalosporin antibiotics

The present invention includes novel compounds of formula where G, H, J, L and M are carbon or nitrogen, R99 is selected from the group consisting of sulfur, SO, SO2, NH, N-alkyl, oxygen, C 3BOND C (cis or trans), and C 3BOND C, and R12 is NR13R14, The invention also includes the pharmacologically acceptable salts which exhibit antibiotic activity against a wide spectrum of organisms including organisms which are resistant to beta -lactam antibiotics and are useful as antibacterial agents. The invention also relates to novel intermediates useful for making the novel compounds of the present invention and to novel methods for producing the novel compounds and intermediate compounds.

Cephalosporin antibiotics

The present invention includes novel compounds of formula where A, B, D, and E are selected from the group consisting of carbon, nitrogen and sulfur, R99 is selected from the group consisting of sulfur, SO, S02, NH, N-alkyl, oxygen, C=C (cis or trans), and C 3BOND C, and R12 is NR13R14, The invention also includes the pharmacologically acceptable salts which exhibit antibiotic activity against a wide spectrum of organisms including organisms which are resistant to beta -lactam antibiotics and are useful as antibacterial agents. The invention also relates to novel intermediates useful for making the novel compounds of the present invention and to novel methods for producing the novel compounds and intermediate compounds.